Diagnostic labs pin hopes on Covid-19 test bouquets to revive revenues

Non-Covid revenues are back to 80% of Jan levels. Some expect demand to be 1.2 times pre-Covid level by Diwali

Sohini Das | Mumbai Last Updated at September 2, 2020 09:55 IST

Diagnostics firms pin their hopes on Covid-19 tests bouquet as a steady source of revenue in not just the coming quarters, but also in the long term.

As such non-Covid revenues, labs claimed, were back to 80 per cent of January levels. "Covid-19 tests are already a part of our 500-tests portfolio, and they are here to stay for a longtime, lets say 10-15 years," said A Velumani, promoter, chairman and managing director, Thyrocare Technologies. The lab chain saw revenue from the wellness related tests decline in the first quarter, as non-essential testing was reduced in the ...

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST Rs

Key stories on business-standard.com are available to premium subscribers only.

Already a premium subscriber? LOGIN NOW

Read our full coverage on Diagnostics

First Published: Wed, September 02 2020. 09:55 IST

Premium Services In Partnership with


Dear Guest,

Diagnostic labs pin hopes on Covid-19 test bouquets to revive revenues

Non-Covid revenues are back to 80% of Jan levels. Some expect demand to be 1.2 times pre-Covid level by Diwali

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST Rs

Already a premium subscriber? LOGIN NOW

Connect with BS